(+) -Ketoconazole [CAS 142128-59-4]
(+) -Ketoconazole [CAS 142128-59-4]
SKU:QM-0157482-01
Couldn't load pickup availability
Request quote or documents
![(+) -Ketoconazole [CAS 142128-59-4]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
(+) -Ketoconazole ((+) -R 41400) is an imidazole anti-fungal agent, a CYP3A4 inhibitor. Target: CYP3A4 (+) -Ketoconazole, an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections [1]. (+) -Ketoconazole also is a cytochrome P450 inhibitor [2]. (+) -Ketoconazole (KTZ), on the antischistosomal potential of these quinolines against Schistosoma mansoni infection by evaluating parasitological, histopathological, and biochemical parameters. Mice were classified into 7 groups: uninfected untreated (I), infected untreated (II), infected treated orally with PZQ (1,000 mg/kg) (III), QN (400 mg/kg) (IV), KTZ (10 mg/kg) +QN as group IV (V), HF (400 mg/kg) (VI), and KTZ (as group V) +HF (as group VI) (VII) . KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone. This was accompanied with more reduction in female (89.0% and 79.3%), total worms (81.4% and 70.3%), and eggs burden (hepatic; 83.8%, 66.0% and intestinal; 68%, 64.5%), respectively, and encountering the granulomatous reaction to parasite eggs trapped in the liver [3]. Clinical indications: Candida infection; Dermatophytosis; Folliculitis FDA Approved Date: Toxicity: teratogenesis; liver injuries; adrenal gland problems
-
CAS Number
[142128-59-4]
-
Molecular Formula
C26H28Cl2N4O4
-
Molecular Weight
531.43
-
Smiles
ClC(C=C1)=CC(Cl)=C1[C@@]2(CN3C=CN=C3)OC[C@H](COC4=CC=C(N5CCN(C(C)=O)CC5)C=C4)O2
-
Target
Cytochrome P450; Fungal
-
Isoform
CYP3
-
Purity
99.79
-
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
-
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
-
Shipping Conditions
Room Temperature
-
Hazard Statement
H315, H319, H320
-
Precautions
H315, H319, H320
Related Products
- QM-0054857-01 α-Ketoglutaric acid (disodium dihydrate) [CAS 1282616-74-3]
- QM-0054003 δ-Hexachlorocyclohexane-13C6
- QM-0053803 γ-Linolenic acid ethyl ester-d5
- QM-0052819-01 Zolpidem phenyl-4-carboxylic acid ethyl ester-d6 [CAS 1216455-48-9]
- QM-0052711 α-D-Glucopyranoside, 2-chloro-4-nitrophenyl, 2,3,4,6-tetraacetate [CAS 153823-58-6]
- QM-0052492-01 α-D-Galactopyranose,2- (acetylamino) -2-deoxy-,1,3,4,6-tetraacetate [CAS 10385-50-9]
- QM-0051894-01 β-D-Glucopyranoside,2-bromoethyl,2,3,4,6-tetraacetate [CAS 16977-78-9]
- QM-0051893 β-D-Glucopyranoside,2-chloro-4-nitrophenyl,2,3,4,6-tetraacetate [CAS 35023-71-3]
- QM-0051820-01 β-D-Glucopyranuronic acid, methyl ester,1,2,3,4-tetrakis (2-methylpropanoate) [CAS 150607-94-6]
- QM-0051622-01 α-Ketoglutaric acid (disodium hydrate)
Other industry favorites
- QM-0054857-01 α-Ketoglutaric acid (disodium dihydrate) [CAS 1282616-74-3]
- QM-0054003 δ-Hexachlorocyclohexane-13C6
- QM-0206023-01 α-Demethylnaproxen [CAS 23981-47-7]
- QM-0203548-01 α-Acetobromo-D-xylose, 95% [CAS 3068-31-3]
- QM-0071124 β-D-Ribofuranose, 3-deoxy-3-fluoro-, 1,2-diacetate 5- (4-methylbenzoate) [CAS 1884324-98-4]
- QM-0131262 [Thr28, Nle31]-Cholecystokinin (25-33), sulfated [CAS 77568-41-3]
- QM-0023392 α-Mycolic acid, keto cis [CAS 2260795-20-6]
- QM-0022881 [R- (Z) ]-4-Amino-3-chloro-2-pen-tenedioicacid [CAS 90288-29-2]
- QM-0167516 α-D-Glucopyranoside, methyl 4-deoxy-4-fluoro,2,3,6-tribenzoate [CAS 84065-98-5]
- QM-0166583-01 β-D-Galactosyl- (1→3) -N-acetyl-D-galactosamine [CAS 3554-90-3]
(+) -Ketoconazole [CAS 142128-59-4]
(+) -Ketoconazole is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.